Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
The duration of effectiveness of SARS-CoV-2 vaccination is not yet known. Here, the authors present preliminary evidence of BNT162b2 vaccine waning across all age groups above 16, with a higher incidence of infection in people who received their second dose early in 2021 compared to later in the yea...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/e47630f157874a9797f16560d3dc86ff |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|